No Picture
News

PreludeDx Presents New Research in Luminal Stage 1 Breast Cancer Patients at the 2019 American Society of Clinical Oncology Annual Meeting

LAGUNA HILLS, Calif., June 18, 2019 /PRNewswire/ –?Prelude Corporation (PreludeDx), a leader in molecular diagnostics and personalized medicine for early stage breast cancer, announced today its compelling data from research on stage 1 breast cance… […]

No Picture
News

BioMarin Announces New England Journal of Medicine Publishes Vosoritide Phase 2 Study Showing Sustained Annualized Growth Up to 42 Months in Children with Achondroplasia

Company Announces Enrollment Met for 2-5 Year-Old Cohort in Separate Phase 2 Study in Infants and Young Children

SAN RAFAEL, Calif., June 18, 2019 /PRNewswire/ –?BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced that the New England Journal of Me… […]

No Picture
News

Berkeley Lights to Launch New T Cell Functional Analytics Platform at the 34 ? Congress of the International Society for Advancement of Cytometry (CYTO)

EMERYVILLE, Calif., June 18, 2019 /PRNewswire/ –?Berkeley Lights, Inc. (BLI),?the leader in digital cell biology, today announced the launch of the LightningTM optofluidic platform, which directly visualizes phenotype and function of 1000s of T ce… […]

No Picture
News

Roche fields first approval for Rozlytrek in the run-up to a showdown with Eli Lilly, Pfizer

While it?s waiting to hear back from FDA regulators, Roche is beginning the victory lap for entrectinib in Japan.
Roche is giving Loxo Oncology ? and Eli Lilly, which wagered $8 billion on the biotech ? a run for their money with this tumor-agnostic dr… […]